NCT07411807 Study of the Effectiveness of a Systematic Minimal Early Intervention on Care Engagement in Adults With Eating Disorders Requesting Specialized Treatment.
| NCT ID | NCT07411807 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier St Anne |
| Condition | Eating Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 215 participants |
| Start Date | 2025-12-29 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 215 participants in total. It began in 2025-12-29 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Eating disorders (EDs) are complex psychiatric conditions-such as anorexia nervosa and bulimia nervosa-often emerging in young adulthood and associated with high morbidity and mortality. Despite their severity, access to specialized care remains difficult, delayed by shame, stigma, and a lack of insight among patients, as well as long waiting times and limited specialized resources. The AGIS-TCA pilot study aims to evaluate the effectiveness of a systematic minimal early intervention designed to reduce the number of patients lost to follow-up between their request for specialized care and the actual start of treatment. This monocentric, low-risk interventional study will be conducted at the Clinique des Maladies Mentales et de l'Encéphale (CMME), GHU Paris Psychiatrie \& Neurosciences. The intervention includes three early, structured telephone calls and five online support group sessions offered during the waiting period for care. The main objective is to determine whether this proactive approach decreases attrition rates ("lost to follow-up") compared with a historical cohort. Secondary objectives include assessing the acceptability of early phone contact, adherence to support groups, and describing the clinical and sociodemographic profiles of patients requesting care or lost to follow-up. The expected benefit is to facilitate timely access to care for vulnerable patients, prevent symptom worsening, and strengthen engagement in treatment pathways. Risks and constraints are minimal, as participation involves only remote interactions without any invasive procedures.
Eligibility Criteria
Inclusion Criteria: * Individual who has submitted a request for care to the CMME for an eating disorder (anorexia nervosa or bulimia) * Adult (18 years or older) Resident of the Île-de-France region Exclusion Criteria: * Body mass index (BMI) greater than 30 kg/m²: these patients will be directed, from the first telephone contact, to structures or care networks that can offer appropriate treatment. Poor understanding of the French language Sensory impairment significantly affecting telephone communication Patient currently receiving care at a specialized eating disorder facility at the time of the call Patient not consenting to participate in the study Subject under legal protection measures (guardianship or curatorship)
Contact & Investigator
MARION Mme DELOULAY, Nurse
PRINCIPAL INVESTIGATOR
Hôpital Sainte-Anne
Frequently Asked Questions
Who can join the NCT07411807 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07411807 currently recruiting?
Yes, NCT07411807 is actively recruiting participants. Contact the research team at ouiza.manseur@ghu-paris.fr for enrollment information.
Where is the NCT07411807 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT07411807 clinical trial?
NCT07411807 is sponsored by Centre Hospitalier St Anne. The principal investigator is MARION Mme DELOULAY, Nurse at Hôpital Sainte-Anne. The trial plans to enroll 215 participants.